vs
Side-by-side financial comparison of LXP Industrial Trust (LXP) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $86.7M, roughly 1.7× LXP Industrial Trust). LXP Industrial Trust runs the higher net margin — 33.2% vs 7.8%, a 25.4% gap on every dollar of revenue. On growth, LXP Industrial Trust posted the faster year-over-year revenue change (-14.0% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 0.3%).
LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
LXP vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.7M | $151.7M |
| Net Profit | $28.8M | $11.8M |
| Gross Margin | 81.5% | 30.4% |
| Operating Margin | 34.6% | 20.4% |
| Net Margin | 33.2% | 7.8% |
| Revenue YoY | -14.0% | -41.1% |
| Net Profit YoY | — | -80.8% |
| EPS (diluted) | — | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.7M | $151.7M | ||
| Q3 25 | $86.9M | $267.8M | ||
| Q2 25 | $87.7M | $244.0M | ||
| Q1 25 | $88.9M | $211.8M | ||
| Q4 24 | $100.9M | $257.6M | ||
| Q3 24 | $85.6M | $78.8M | ||
| Q2 24 | $85.8M | $76.1M | ||
| Q1 24 | $86.3M | $67.5M |
| Q4 25 | $28.8M | $11.8M | ||
| Q3 25 | $36.3M | $55.4M | ||
| Q2 25 | $29.1M | $-17.7M | ||
| Q1 25 | $19.0M | $21.2M | ||
| Q4 24 | — | $61.6M | ||
| Q3 24 | $6.3M | $-8.8M | ||
| Q2 24 | $5.4M | $-364.0K | ||
| Q1 24 | $-269.0K | $-364.0K |
| Q4 25 | 81.5% | 30.4% | ||
| Q3 25 | 82.3% | 57.8% | ||
| Q2 25 | 81.9% | 51.2% | ||
| Q1 25 | 80.7% | 55.9% | ||
| Q4 24 | 85.3% | 55.0% | ||
| Q3 24 | 82.5% | 27.8% | ||
| Q2 24 | 82.0% | 29.7% | ||
| Q1 24 | 82.4% | 15.1% |
| Q4 25 | 34.6% | 20.4% | ||
| Q3 25 | 50.4% | 48.7% | ||
| Q2 25 | 33.7% | 13.8% | ||
| Q1 25 | 21.8% | 38.1% | ||
| Q4 24 | — | 44.4% | ||
| Q3 24 | 7.9% | 12.3% | ||
| Q2 24 | 6.9% | 7.0% | ||
| Q1 24 | 1.0% | 2.1% |
| Q4 25 | 33.2% | 7.8% | ||
| Q3 25 | 41.7% | 20.7% | ||
| Q2 25 | 33.2% | -7.3% | ||
| Q1 25 | 21.4% | 10.0% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | 7.4% | -11.2% | ||
| Q2 24 | 6.3% | -0.5% | ||
| Q1 24 | -0.3% | -0.5% |
| Q4 25 | — | $2.34 | ||
| Q3 25 | $0.12 | $7.76 | ||
| Q2 25 | $0.09 | $-2.95 | ||
| Q1 25 | $0.06 | $3.33 | ||
| Q4 24 | — | $11.56 | ||
| Q3 24 | $0.02 | $-1.72 | ||
| Q2 24 | $0.01 | $-0.07 | ||
| Q1 24 | $-0.01 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $170.4M | $185.6M |
| Total DebtLower is stronger | $1.4B | — |
| Stockholders' EquityBook value | $2.0B | $329.4M |
| Total Assets | $3.5B | $918.5M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $170.4M | $185.6M | ||
| Q3 25 | $229.7M | $166.0M | ||
| Q2 25 | $71.0M | $96.7M | ||
| Q1 25 | $70.9M | $84.7M | ||
| Q4 24 | $101.8M | $40.6M | ||
| Q3 24 | $55.0M | $46.9M | ||
| Q2 24 | $48.7M | $40.8M | ||
| Q1 24 | $293.8M | $30.0M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.0B | $329.4M | ||
| Q3 25 | $2.1B | $317.2M | ||
| Q2 25 | $2.1B | $235.3M | ||
| Q1 25 | $2.1B | $176.9M | ||
| Q4 24 | $2.1B | $132.4M | ||
| Q3 24 | $2.1B | $60.4M | ||
| Q2 24 | $2.1B | $62.7M | ||
| Q1 24 | $2.2B | $63.0M |
| Q4 25 | $3.5B | $918.5M | ||
| Q3 25 | $3.7B | $964.5M | ||
| Q2 25 | $3.7B | $841.0M | ||
| Q1 25 | $3.8B | $761.9M | ||
| Q4 24 | $3.8B | $655.3M | ||
| Q3 24 | $3.9B | $438.5M | ||
| Q2 24 | $3.9B | $422.4M | ||
| Q1 24 | $4.2B | $404.3M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.73× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $188.7M | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | 6.56× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $188.7M | $70.4M | ||
| Q3 25 | $63.5M | $99.5M | ||
| Q2 25 | $44.3M | $27.3M | ||
| Q1 25 | $39.0M | $51.0M | ||
| Q4 24 | $211.2M | $54.0K | ||
| Q3 24 | $64.6M | $6.8M | ||
| Q2 24 | $38.5M | $13.3M | ||
| Q1 24 | $38.9M | $3.1M |
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | 6.56× | 5.95× | ||
| Q3 25 | 1.75× | 1.80× | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LXP
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
